Importance of immunopharmacogenomics in cancer treatment: Patient selection and monitoring for immune checkpoint antibodies
Author:
Affiliation:
1. Pritzker School of Medicine University of Chicago ChicagoIllinois USA
2. Section of Hematology/Oncology and Center for Personalized Therapeutics Department of Medicine University of Chicago Chicago Illinois USA
Publisher
Wiley
Subject
Cancer Research,Oncology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.12862
Reference59 articles.
1. FDA expands approved use of Opdivo to treat lung cancer. FDA Press Release (Serial online) 2015 March 1(1): [Cited September 10 2015.] Available from URL:http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm436534.htm
2. The immune checkpoint inhibitors: where are we now?
3. PeddicordS.FDA approves Keytruda for advanced non‐small cell lung cancer. FDA Press Release (Serial online) 2015 October 1(1): [Cited October 9 2015]. Available from URL:http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm465444.htm
4. Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4
5. CD28/B7 SYSTEM OF T CELL COSTIMULATION
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Impact of drug dispersion on tumor-effector dynamics during combined chemo-immunotherapy with sensitivity analysis;Applied Mathematical Modelling;2024-10
2. An EBNA1-YAP signaling axis drives immune escape through CD276 in EBV-associated gastric cancer;2024-01-19
3. Identification and validation of a novel signature based on T cell marker genes to predict prognosis, immunotherapy response and chemotherapy sensitivity in head and neck squamous carcinoma by integrated analysis of single-cell and bulk RNA-sequencing;Heliyon;2023-11
4. Mortality Prediction of Various Cancer Patients via Relevant Feature Analysis and Machine Learning;SN Computer Science;2023-03-16
5. CAR-T Cells in the Treatment of Ovarian Cancer: A Promising Cell Therapy;Biomolecules;2023-03-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3